At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Not Yet Opened 01-13 16:00:00 EST
883.91
+0.42
+0.05%
High886.99Low876.99Vol500.35M
Open883.49D1 Closing883.49Amplitude1.13%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O14.30BT/O Rate--Tradable Shares0.00
P/B5.391402ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

HUTCHMED (00013) Announces Publication of SACHI Phase III Study Results in The Lancet
Stock News  ·  12:16
HUTCHMED (00013) Announces Publication of SACHI Phase III Study Results in The Lancet
What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?
Benzinga_recent_news  ·  12:01
What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?
These 20 Cheap S&P 500 Stocks Can Cushion the Blow in a Market Downturn
Dow Jones  ·  11:50
These 20 Cheap S&P 500 Stocks Can Cushion the Blow in a Market Downturn
Director Donald Allen Williams Acquires Common Shares of Palisade Bio Inc
Reuters  ·  10:43
Director Donald Allen Williams Acquires Common Shares of Palisade Bio Inc
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc.
TIPRANKS  ·  10:01
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc.
Celltrion Announces Plans to Expand U.S. Manufacturing and R&D Capabilities, Advance Innovative Drug Pipeline, and Strengthen Global Supply Chain
Reuters  ·  09:19
Celltrion Announces Plans to Expand U.S. Manufacturing and R&D Capabilities, Advance Innovative Drug Pipeline, and Strengthen Global Supply Chain
MBX Biosciences Unveils Canvuparatide Phase 2 Data for Hypoparathyroidism Therapy
Reuters  ·  08:03
MBX Biosciences Unveils Canvuparatide Phase 2 Data for Hypoparathyroidism Therapy
Phibro Animal Health CEO Jack Bendheim Reports Sale of Common Shares
Reuters  ·  07:53
Phibro Animal Health CEO Jack Bendheim Reports Sale of Common Shares
BRIEF-Eli Lilly CEO Says Could Be Thinking About Guiding 2026 More Broadly In A Range Than We Have Before - JPM Conf
Reuters  ·  07:06
BRIEF-Eli Lilly CEO Says Could Be Thinking About Guiding 2026 More Broadly In A Range Than We Have Before - JPM Conf
Eli Lilly CEO Says Need to Know Volume of Patients Getting Obesity Drugs Under US Medicare Drug Plans and Self-Paying Patients Outside US to Predict 2026 Sales
THOMSON REUTERS  ·  06:58
Eli Lilly CEO Says Need to Know Volume of Patients Getting Obesity Drugs Under US Medicare Drug Plans and Self-Paying Patients Outside US to Predict 2026 Sales
Eli Lilly CEO Says Could Be Thinking About Guiding 2026 More Broadly in a Range Than We Have Before - JPM Conference
THOMSON REUTERS  ·  06:58
Eli Lilly CEO Says Could Be Thinking About Guiding 2026 More Broadly in a Range Than We Have Before - JPM Conference
Enliven Therapeutics COO Anish Patel Reports Disposal of Common Shares
Reuters  ·  06:54
Enliven Therapeutics COO Anish Patel Reports Disposal of Common Shares
Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares
Reuters  ·  06:38
Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares
Crinetics Pharmaceuticals Inc. Publishes Transcript of J.P. Morgan Healthcare Conference Presentation
Reuters  ·  06:03
Crinetics Pharmaceuticals Inc. Publishes Transcript of J.P. Morgan Healthcare Conference Presentation
Mixed options sentiment in Tilray with shares up 1.08%
TIPRANKS  ·  06:00
Mixed options sentiment in Tilray with shares up 1.08%
Currenc Group Faces Nasdaq Deficiency Notice Over Missed Annual Meeting
Reuters  ·  05:52
Currenc Group Faces Nasdaq Deficiency Notice Over Missed Annual Meeting
Liquidia Chief Human Resource Officer Sarah Krepp Reports Disposal of Common Shares
Reuters  ·  05:37
Liquidia Chief Human Resource Officer Sarah Krepp Reports Disposal of Common Shares
China SXT Pharmaceuticals Raises $9.1 Million in Registered Direct Offering with Pre-Funded Warrants
TIPRANKS  ·  05:36
China SXT Pharmaceuticals Raises $9.1 Million in Registered Direct Offering with Pre-Funded Warrants
Aspire Biopharma Director Surendra Ajjarapu Resigns
Reuters  ·  05:31
Aspire Biopharma Director Surendra Ajjarapu Resigns
Liquidia Corporation Files Initial Beneficial Ownership Statement for Chief Development Officer Sanjeev Khindri
Reuters  ·  05:31
Liquidia Corporation Files Initial Beneficial Ownership Statement for Chief Development Officer Sanjeev Khindri

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--